Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy

Mineralocorticoid receptor antagonists (MRAs) slow cardiomyopathy in patients with Duchenne muscular dystrophy (DMD) and improve skeletal muscle pathology and function in dystrophic mice. However, glucocorticoids, known antiinflammatory drugs, remain a standard of care for DMD, despite substantial s...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Zachary M. Howard, Chetan K. Gomatam, Charles P. Rabolli, Jeovanna Lowe, Arden B. Piepho, Shyam S. Bansal, Federica Accornero, Jill A. Rafael-Fortney
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Clinical investigation 2022-10-01
Saila:	JCI Insight
Gaiak:	Muscle biology
Sarrera elektronikoa:	https://doi.org/10.1172/jci.insight.159875
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!